PMID- 29775753 OWN - NLM STAT- MEDLINE DCOM- 20190705 LR - 20190705 IS - 1879-0038 (Electronic) IS - 0378-1119 (Linking) VI - 671 DP - 2018 Sep 10 TI - Long non-coding RNA biomarker for human laryngeal squamous cell carcinoma prognosis. PG - 96-102 LID - S0378-1119(18)30535-3 [pii] LID - 10.1016/j.gene.2018.05.046 [doi] AB - Long non-coding RNAs (lncRNA) were discovered in tumors. The regulation of lncRNA in human laryngeal squamous cell carcinoma (LSCC) remains incomplete. Uncovering the potential of lncRNA to stratify the prognosis of LSCC and streamline the vast amount of clinical information will affect medical interventions. The surgical resected LSCC tissues, adjacent non-cancerous tissues (ANCT) and lymph node metastatic tissue (LNM) were collected from 76 patients for lncRNA AC008440.10 expression assay. The stages of LSCC and LNM were classified accordingly. We integrated the epigenetic information with enhanced CT imaging and pathological evaluations to predict the patients' survival by comprehensive statistical algorithms using equal weighting. Significant downregulation of lncRNA AC008440.10 was detected in LSCC tumor and metastatic lymph node in advanced stage of patient samples compared with those in early stage. The pattern of differentially expressed AC008440.10 displayed a clear trend that significantly related to tumor progression. The downregulation of lncRNA AC008440.10 correlates with increasing risk of metastasis, poor prognosis and patient survival. The potential for lncRNA AC008440.10 to be developed as a novel biomarker for stratification of the prognosis was especially promising when clinic parameters were hybridized with equal weight, and using a panel of complementary parameters yielded a more powerful predictability of LSCC prognosis than any single parameter individually. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Chen, Jingjing AU - Chen J AD - Department of Otorhinolaryngology (Head and Neck Surgery), Ningbo City Medical Treatment Center Lihuili Hospital, Ningbo 315000, Zhejiang, China. FAU - Shen, Zhisen AU - Shen Z AD - Department of Otorhinolaryngology (Head and Neck Surgery), Ningbo City Medical Treatment Center Lihuili Hospital, Ningbo 315000, Zhejiang, China. FAU - Deng, Hongxia AU - Deng H AD - Department of Otorhinolaryngology (Head and Neck Surgery), Ningbo City Medical Treatment Center Lihuili Hospital, Ningbo 315000, Zhejiang, China. FAU - Zhou, Wei AU - Zhou W AD - Departmcnt of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China, 310016. FAU - Liao, Qi AU - Liao Q AD - Department of Preventative Medicine, Zhejiang Provincial Key Laboratory of Pathological and Physiological Technology, Medical School of Ningbo University, Ningbo 315211, Zhejiang, China. FAU - Mu, Ying AU - Mu Y AD - EagleImmune, Inc., 11361 Bishops Gate Ln, Laurel, MD 20723, USA. Electronic address: yingm6@gmail.com. LA - eng PT - Journal Article DEP - 20180605 PL - Netherlands TA - Gene JT - Gene JID - 7706761 RN - 0 (Biomarkers, Tumor) RN - 0 (RNA, Long Noncoding) SB - IM MH - Adult MH - Aged, 80 and over MH - Biomarkers, Tumor/*genetics MH - Carcinoma, Squamous Cell/genetics/*surgery MH - *Down-Regulation MH - Epigenesis, Genetic MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Laryngeal Neoplasms/genetics/*surgery MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Prognosis MH - RNA, Long Noncoding/*genetics MH - Survival Analysis OTO - NOTNLM OT - Biomarker OT - Laryngeal squamous cell carcinoma OT - Lymph node metastasis OT - Prognosi OT - lncRNA AC008440.10 EDAT- 2018/05/19 06:00 MHDA- 2019/07/06 06:00 CRDT- 2018/05/19 06:00 PHST- 2018/03/22 00:00 [received] PHST- 2018/05/13 00:00 [accepted] PHST- 2018/05/19 06:00 [pubmed] PHST- 2019/07/06 06:00 [medline] PHST- 2018/05/19 06:00 [entrez] AID - S0378-1119(18)30535-3 [pii] AID - 10.1016/j.gene.2018.05.046 [doi] PST - ppublish SO - Gene. 2018 Sep 10;671:96-102. doi: 10.1016/j.gene.2018.05.046. Epub 2018 Jun 5.